Circulating microparticles are elevated in haemophiliacs and non-haemophilic individuals aged <18 years

Valérie Proulle1, Bénédicte Hugel, Benoit Guillet

  • 1Service d'Hématologie Biologique, AP-HP, Hôpital Bicêtre, Faculté de Médecine Paris XI, Le Kremlin Bicêtre, France. valerie.proulle@bct.aphp.fr

Insights

Platelet stimulation causes membrane changes and microparticle release. Higher microparticle levels were observed in both haemophiliacs and non-haemophiliacs under 18 years old.

Area of Science:

  • Biochemistry
  • Hematology
  • Cell Biology

Background:

  • Cell stimulation, including platelets, induces plasma membrane remodelling.
  • This remodelling involves phosphatidylserine (PS) externalisation and the shedding of PS-rich microparticles (MPs).
  • MPs play a role in thrombin generation by facilitating coagulation enzyme complex assembly.

Purpose of the Study:

  • To investigate in vivo membrane remodelling and microparticle (MP) levels.
  • To further understand the characteristics of MPs in haemophiliacs.
  • To compare MP levels between haemophiliacs and non-haemophiliacs.

Main Methods:

  • Studied MP levels and characteristics in 79 haemophiliacs and 62 non-haemophiliacs.
  • Analyzed heterogeneity in MP levels across participants.
  • Compared MP levels based on age groups.

Main Results:

  • Observed heterogeneity in MP levels in both haemophiliacs and non-haemophiliacs.
  • Found significantly higher MP levels in individuals younger than 18 years across both groups.
  • Indicated that age is a critical factor in MP levels.

Conclusions:

  • In vivo membrane remodelling and MP shedding are complex processes.
  • Age significantly influences MP levels, with higher levels in younger individuals (<18 years).
  • This age-dependent finding is crucial for interpreting MP levels in research and clinical settings, especially in pediatric populations.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.